Northwest Biotherapeutics, Inc. (NWBO)
0.1696
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Northwest Biotherapeutics Price : 0.1696 for Sept. 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 04, 2026 | 0.1698 | 0.1711 | 0.1689 | 0.1696 | 1.723M |
| Sep 03, 2026 | 0.1696 | 0.1711 | 0.1666 | 0.1699 | 1.453M |
| Sep 02, 2026 | 0.1685 | 0.171 | 0.1645 | 0.1694 | 3.331M |
| Sep 01, 2026 | 0.172 | 0.1745 | 0.1672 | 0.168 | 2.049M |
| Aug 31, 2026 | 0.1873 | 0.1975 | 0.1667 | 0.1702 | 18.52M |
| Aug 28, 2026 | 0.1795 | 0.225 | 0.1758 | 0.1896 | 10.43M |
| Aug 27, 2026 | 0.1731 | 0.1805 | 0.1708 | 0.1791 | 2.418M |
| Aug 26, 2026 | 0.1739 | 0.1775 | 0.1712 | 0.173 | 1.262M |
| Aug 25, 2026 | 0.1751 | 0.1751 | 0.1663 | 0.1739 | 1.936M |
| Aug 24, 2026 | 0.17 | 0.177 | 0.1663 | 0.1725 | 5.231M |
| Aug 21, 2026 | 0.1721 | 0.179 | 0.1631 | 0.1696 | 3.194M |
| Aug 20, 2026 | 0.1799 | 0.18 | 0.17 | 0.1713 | 2.217M |
| Aug 19, 2026 | 0.1839 | 0.1848 | 0.1711 | 0.1776 | 1.811M |
| Aug 18, 2026 | 0.1805 | 0.188 | 0.1751 | 0.1799 | 2.180M |
| Aug 17, 2026 | 0.1958 | 0.2074 | 0.1803 | 0.1825 | 4.396M |
| Aug 14, 2026 | 0.1949 | 0.1949 | 0.1885 | 0.192 | 1.431M |
| Aug 13, 2026 | 0.191 | 0.1947 | 0.1851 | 0.19 | 1.490M |
| Aug 12, 2026 | 0.1901 | 0.1919 | 0.185 | 0.1888 | 2.691M |
| Aug 11, 2026 | 0.186 | 0.1959 | 0.185 | 0.19 | 2.619M |
| Aug 10, 2026 | 0.1845 | 0.1999 | 0.184 | 0.186 | 2.619M |
| Aug 07, 2026 | 0.1849 | 0.2077 | 0.18 | 0.1836 | 8.233M |
| Aug 06, 2026 | 0.1649 | 0.1798 | 0.1588 | 0.1785 | 5.250M |
| Aug 05, 2026 | 0.16 | 0.1640 | 0.157 | 0.164 | 1.802M |
| Aug 04, 2026 | 0.16 | 0.169 | 0.158 | 0.161 | 1.216M |
| Aug 03, 2026 | 0.1607 | 0.1699 | 0.1563 | 0.1595 | 2.792M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 28.02 |
| Alnylam Pharmaceuticals, Inc. | 266.11 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.37 |
| Vericel Corp. | 40.19 |
Price Related Metrics
| PS Ratio | 122.71 |
| Earnings Yield | -14.97% |
| Market Cap | 283.20M |